Search for drugs:
Typing the drug name to query
CARIPRAZINE
DIR Classification
Classification:Most-DIR concern
Severity Score:4
Description in Drug Labeling: View Full Labeling: SPL in DailyMed | PDF
- CLINICAL PHARMACOLOGY
- Pharmacodynamics
- Effect on QTc Interval
- At a dose three-times the maximum recommended dose, cariprazine does not prolong the QTc interval to clinically relevant extent.
Postmarketing Surveillance
Contingency Table:
Current Drug
Other Drugs
Rhabdomyolysis
2
42910
Other ADRs
251
14117028
Odds Ratio = 2.622
Drug Property Information
ATC Code(s):
- N05AX15 - cariprazine
- N05AX - Other antipsychotics
- N05A - ANTIPSYCHOTICS
- N05 - PSYCHOLEPTICS
- N - NERVOUS SYSTEM
Active Ingredient:cariprazine
Active Ingredient UNII:F6RJL8B278
Drugbank ID:DB06016
PubChem Compound:11154555
CAS Number:839712-12-8
Dosage Form(s):capsule, gelatin coated; kit
Route(s) Of Administrator:oral
Daily Dose:
Chemical Structure: 
SMILE Code:
CN(C)C(=O)NC1CCC(CC1)CCN2CCN(CC2)C3=C(C(=CC=C3)Cl)Cl
CN(C)C(=O)NC1CCC(CC1)CCN2CCN(CC2)C3=C(C(=CC=C3)Cl)Cl
Reference
COHORT STUDY:
N/AOTHER REFERENCE(S):
N/ADisclaimer:
The content of this database of rhabdomyolysis is intended for educational and scientific research purposes only. It is not intended as a substitute for professional medical advice, diagnosis or treatment.
The views presented in this website do not necessarily reflect current or future opinion or policy of the US Food and Drug Administration. Any mention of commercial products is for clarification and not intended as endorsement.